Industry sessions
The EADV industry partners organize several sessions as an adjunct to the EADV scientific sessions. The sessions are organized by the companies and feature presentations by experts in the field, panel discussions and other type of sessions.
Industry session types
The industry sessions are a valuable way to learn about new research, techniques or treatments in the field of dermatology and venereology. In addition, some sessions will focus on sharing information about new products, services and/or technologies available.
At the EADV Congress, two different types of industry sessions are organized:
Satellite Symposia
Satellite symposia are organized in the main session rooms and take place during the morning, lunch and in the evening, after the last scientific sessions. These sessions last between 45, 60 and 90 minutes and offer a wider education on the presented topic to remain updated on any progression in the field.
Industry Expert Hubs
Industry expert hubs are organized in Pavillion 7.2.1 (level 2) of the Paris Expo Porte de Versailles. These sessions last 45 minutes and are focused on bringing together a smaller group of experts to discuss more in-depth or to focus on a specific topic.
Industry sessions programme
The session programme will be published here as soon as available.
The industry session organiser is solely responsible for keeping any of its industry sessions activities compliant with all relevant laws and regulations. EADV is not involved with in or have any control over the content, quality, organization, operation, scientific integrity of the activity and materials. EADV will not be involved in the selection of speakers, moderators and other faculty.
Access to industry sessions
As a multidisciplinary audience will be attending the EADV Congress 2025, please make sure to select the right category, healthcare professionals (HCPs) and non-healthcare professionals (NON-HCPs), during the registration process.
Access to any industry sessions where data or research of prescription medicines is presented will be limited exclusively to healthcare professionals (HCPs) only and Non Members (INDUSTRY).
Industry session organisers may limit participation to certain representative groups independently from EADV recommendations if deemed imperative to the achievement of the intended purpose of the Industry session.
Official Italian Agency for AIFA Procedure
Any Italian pharmaceutical company supporting or participating in a congress abroad, is subjected to an authorization by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124).
The request of authorization must be submitted within 60 days before the starting date of the event. The appointed agency to collect all applications from pharmaceutical companies and file them with the AIFA is:
AIM Group International – AIM Education S.r.l.
Cristina Ghidoli
Via G. Ripamonti, 129
20134 Milan, Italy
Tel. +39 02 56601.1
e-mail: [email protected] – [email protected]
Industry sessions programme
The session programme will be published here as soon as available.
The industry session organiser is solely responsible for keeping any of its industry sessions activities compliant with all relevant laws and regulations. EADV is not involved with in or have any control over the content, quality, organization, operation, scientific integrity of the activity and materials. EADV will not be involved in the selection of speakers, moderators and other faculty.
Access to the industry sessions
As a multidisciplinary audience will be attending the EADV Congress 2025, please make sure to select the right category, healthcare professionals (HCPs) and non-healthcare professionals (NON-HCPs), during the registration process.
Access to any industry sessions where data or research of prescription medicines is presented will be limited exclusively to healthcare professionals (HCPs) only and Non Members (INDUSTRY).
Industry session organisers may limit participation to certain representative groups independently from EADV recommendations if deemed imperative to the achievement of the intended purpose of the Industry session.
Official Italian Agency for AIFA Procedure
Any Italian pharmaceutical company supporting or participating in a congress abroad, is subjected to an authorization by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124).
The request of authorization must be submitted within 60 days before the starting date of the event. The appointed agency to collect all applications from pharmaceutical companies and file them with the AIFA is:
AIM Group International – AIM Education S.r.l.
Cristina Ghidoli
Via G. Ripamonti, 129
20134 Milan, Italy
Tel. +39 02 56601.1
e-mail: [email protected] – [email protected]
Don’t hesitate to contact us for more information – [email protected]
